Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine in Cancer Cachexia-Associated Anorexia
NCT05243251Phase 3Completed
- Sponsor
- Cairo University
- Start
- Dec 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in anorexia nervosa (AN) comparing Olanzapine Arm with Placebo Arm (2 arms). Primary endpoint: Loss of Appetite Score at 1 week. Started Dec 2021; status: completed.
02
Drugs
olanzapine
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT05243251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05243251.